One page, thousands of outlets. See who else covered it.
Key PointsVanEck Pharmaceutical ETF offers a lower-volatility profile and a higher 1.9% dividend yield compared to State Street SPDR S&P Biotech ETF.
We haven't written up this one. Nasdaq Markets has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Mice with persistent anxiety are quicker to learn about alcohol-related rewards than their less anxious peers. A new study reveals this connection is controlled by the brain’s endocannabinoid system…
Researchers at the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have identified a 'master switch' responsible for driving tumor growth in an aggressive form of…
Tavneos’ withdrawal from the European market is creating challenges for CSL Vifor. CSL Limited, Vifor’s Australian parent company, said Vifor’s revenue is expected to fall by roughly a quarter in…
Kwara State launches a comprehensive roadmap to eliminate viral hepatitis as a public health threat by 2030, aligning with WHO global targets.
Researchers found that employees who "doomscroll" at work suffer hidden costs that extend beyond lost productivity.
In this GEN webinar, experts from Rose BioSolutions, a CDMO and Cell Solutions organization formed from Charles River Laboratories’ businesses, will discuss how integrating regulatory strategy at the…
